AI Weekly: With RPA on the rise, security challenges remain

For example, San Jose-based RPA firm Automation Anywhere recently worked with a pharmaceutical company in Europe to accelerate the research and approval of COVID-19 vaccines by augmenting reporting. RPA startup UiPath has also assisted with efforts around the pandemic, for instance helping the U.S. Department of Homeland Security use software bots to perform coronavirus-related data analysis. Deloitte reports that organizations that have implemented and scaled RPA see a return on investment within 12 months. And according to Everest Group, top performers earned nearly four times on their RPA investments while other enterprises earned nearly double. This isn't to suggest that RPA is without its challenges.